FORGHIERI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 7.456
EU - Europa 3.157
AS - Asia 971
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 5
OC - Oceania 5
Totale 11.624
Nazione #
US - Stati Uniti d'America 7.430
GB - Regno Unito 1.185
IT - Italia 550
SE - Svezia 514
CN - Cina 327
DE - Germania 260
HK - Hong Kong 205
SG - Singapore 166
UA - Ucraina 166
FI - Finlandia 140
TR - Turchia 119
FR - Francia 102
BG - Bulgaria 68
IN - India 52
BE - Belgio 35
CZ - Repubblica Ceca 33
ID - Indonesia 20
VN - Vietnam 20
IE - Irlanda 15
KR - Corea 15
IR - Iran 14
LT - Lituania 14
BZ - Belize 13
CA - Canada 13
EU - Europa 12
JP - Giappone 12
NL - Olanda 12
RU - Federazione Russa 12
BR - Brasile 7
ES - Italia 7
CH - Svizzera 6
MY - Malesia 6
PL - Polonia 6
AU - Australia 5
DK - Danimarca 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AT - Austria 4
BD - Bangladesh 3
CL - Cile 3
GR - Grecia 3
TW - Taiwan 3
CO - Colombia 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
MZ - Mozambico 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 11.624
Città #
Fairfield 1.188
Southend 978
Woodbridge 746
Ashburn 678
Chandler 591
Houston 558
Ann Arbor 455
Seattle 443
Cambridge 357
Wilmington 335
Nyköping 331
Jacksonville 328
Dearborn 317
Hong Kong 198
Modena 184
New York 110
Beijing 101
Singapore 86
Helsinki 81
San Diego 80
Fremont 73
Bremen 67
Sofia 67
Princeton 66
Eugene 63
Izmir 63
Bologna 38
Redwood City 34
London 32
Brussels 30
Boardman 28
Shanghai 28
Des Moines 24
Milan 23
Jakarta 19
San Jose 19
Chicago 16
Dong Ket 16
Las Vegas 16
Dublin 14
Hefei 14
Albuquerque 13
Belize City 13
Brno 12
Dallas 12
Kunming 12
Leawood 10
Washington 10
Guangzhou 9
Kilburn 9
Nanjing 9
Paris 9
Pavia 9
Rome 9
Chiswick 8
Munich 8
Norwalk 8
San Mateo 8
Perugia 7
Saint Louis 7
San Francisco 7
Seongnam-si 7
Toronto 7
Wuhan 7
Botucatu 6
Nanchang 6
Rimini 6
Romainville 6
Bangalore 5
Bengaluru 5
Correggio 5
Phoenix 5
Prescot 5
Tokyo 5
Tulare 5
Bari 4
Castelnuovo Rangone 4
Central 4
Columbus 4
Falls Church 4
Genova 4
Ghent 4
Grafing 4
Hanoi 4
Kosice 4
Los Angeles 4
San Giuliano Milanese 4
Vienna 4
Amsterdam 3
Asti 3
Atlanta 3
Bristol 3
Changsha 3
Chengdu 3
Cresserons 3
Dhaka 3
Florence 3
Formigine 3
Hebei 3
Hounslow 3
Totale 9.252
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 278
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 256
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 244
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 239
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 238
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 235
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 227
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 222
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 220
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 212
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 209
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 206
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 205
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 204
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 203
Acute appendicitis in adult neutropenic patients with hematologic malignancies 200
Mucorales-specific T cells in patients with hematologic malignancies 199
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 197
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 197
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 197
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 196
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 194
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 192
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 192
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 191
B cells and herpesviruses: a model of lymphoproliferation 190
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 190
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 189
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 189
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 189
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 186
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 181
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 179
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 179
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 177
How I treat HHV8/KSHV-related diseases in posttransplant patients. 176
Pain and emotional distress in leukemia patients at diagnosis. 172
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 171
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 171
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 165
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 164
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 164
Inflammatory myofibroblastic tumor of the bone marrow. 163
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 161
Philadelphia chromosome-positive acute lymphoblastic leukemia 160
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 158
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 158
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 155
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 153
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 150
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 148
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 147
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 145
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 144
Splenomegaly in hematological malignancies and portal hypertension 143
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 143
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 142
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 140
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 132
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 131
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 131
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 127
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 125
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 114
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 114
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 53
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 39
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 29
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 26
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 20
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 2
Totale 11.838
Categoria #
all - tutte 43.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.491 0 93 100 170 290 410 500 349 250 101 111 117
2020/20212.173 142 132 183 268 231 185 141 251 99 261 141 139
2021/20221.553 69 208 160 96 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.191 33 48 92 88 215 139 137 210 23 22 77 107
2024/2025136 129 7 0 0 0 0 0 0 0 0 0 0
Totale 11.838